Related Experiment Videos
Third-trimester uterine rupture after prostaglandin E2 use for labor induction
R Maymon1, L Haimovich, A Shulman
1Department of Obstetrics and Gynecology B, Sapir Medical Center, Kfar Saba, Israel.
The Journal of Reproductive Medicine
|May 1, 1992
Summary
Prostaglandin E2 effectively induces labor with minimal side effects. However, uterine rupture, though rare, remains a potential risk with prostaglandin use during pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
Background:
- Prostaglandin E2 is a widely used agent for labor induction.
- It is known for its efficacy, even with an unfavorable cervix.
- Obstetric and neonatal side effects are generally infrequent.
Purpose of the Study:
- To review the incidence and characteristics of uterine rupture associated with Prostaglandin E2 use.
- To assess the safety profile of Prostaglandin E2 in labor induction.
Main Methods:
- Literature review of reported cases of uterine rupture.
- Analysis of obstetric and neonatal outcomes.
Main Results:
- Only nine cases of uterine rupture were reported in English literature following Prostaglandin E2 administration.
- Uterine rupture is a rare but documented complication.
Conclusions:
- Prostaglandin E2 is a valuable tool for labor induction with a favorable safety profile.
- Healthcare providers should remain aware of the rare risk of uterine rupture with all prostaglandin compounds.